Keywords: cat, genzyme, amend, collaboration, usa-based, cambridge, antibody

CAT and Genzyme amend collaboration

Article | 29 September 2003

USA-based Genzyme and Cambridge Antibody Technology of the UK have amended their human monoclonal antibody development and commercialization deal. Under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing